Washington Trust Bancorp Q3 EPS $1.07 Beats $0.93 Estimate

Washington Trust Bancorp (NASDAQ:WASH) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $0.93 by 15.05 percent. This is a 0.94 percent increase over earnings of $1.06 per share

byBenzinga Newsdesk

October 25, 2021

1 minute read

RBC Capital Maintains Sector Perform on AcuityAds Holdings, Lowers Price Target to C$3.5

By Benzinga Newsdesk

Today, 9:51 AM

RBC Capital analyst Drew McReynolds maintains AcuityAds Holdings (TSX:AT) with a Sector Perform and lowers the price target from C$5 to C$3.5.

TSX:AT

HC Wainwright & Co. Reiterates Buy on Ocular Therapeutix, Maintains $11 Price Target

By Benzinga Newsdesk

Today, 9:51 AM

HC Wainwright & Co. analyst Yi Chen reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Buy and maintains $11 price target.

OCUL

Here’s How Much You Would Have Made Owning Visa Stock In The Last 5 Years

By Benzinga Insights

Today, 9:51 AM

Visa (NYSE:V) has outperformed the market over the past 5 years by 3.64% on an annualized basis producing an average annual return of 15.65%. Currently, Visa has a market capitalization of $450.87 billion.

Industrial Alliance Initiates Coverage On Neighbourly Pharmacy with Buy Rating, Announces Price Target of C$28

By Benzinga Newsdesk

Today, 9:51 AM

Industrial Alliance initiates coverage on Neighbourly Pharmacy (TSX:NBLY) with a Buy rating and announces Price Target of C$28.

TSX:NBLY

Washington Trust Bancorp Q3 EPS $1.07 Beats $0.93 Estimate

Related Posts

RBC Capital Maintains Sector Perform on AcuityAds Holdings, Lowers Price Target to C$3.5

HC Wainwright & Co. Reiterates Buy on Ocular Therapeutix, Maintains $11 Price Target

Here’s How Much You Would Have Made Owning Visa Stock In The Last 5 Years

Industrial Alliance Initiates Coverage On Neighbourly Pharmacy with Buy Rating, Announces Price Target of C$28